Amy Quinlan's most recent trade in Vor Biopharma Inc was a trade of 206 Common Stock done at an average price of $0.9 . Disclosure was reported to the exchange on Nov. 6, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Vor Biopharma Inc | Amy Quinlan | Vice President of Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.86 per share. | 06 Nov 2024 | 206 | 50,312 | - | 0.9 | 177 | Common Stock |
Vor Biopharma Inc | Amy Quinlan | Vice President of Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.80 per share. | 01 Nov 2024 | 343 | 50,518 | - | 0.8 | 274 | Common Stock |
Vor Biopharma Inc | Amy Quinlan | Vice President of Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.83 per share. | 01 Aug 2024 | 4,402 | 50,861 | - | 0.8 | 3,654 | Common Stock |
Vor Biopharma Inc | Amy Quinlan | Vice President of Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. | 01 Aug 2024 | 343 | 55,469 | - | 0.9 | 322 | Common Stock |
Vor Biopharma Inc | Amy Quinlan | Vice President of Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.87 per share. | 01 Aug 2024 | 206 | 55,263 | - | 0.9 | 179 | Common Stock |